Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
CD Capital is a venture capital firm established in 2013 and headquartered in Shanghai, China. The firm has over $1.4 billion in assets under management, focusing primarily on the medical technology and life sciences sectors. Since its inception, CD Capital has aimed to identify and support high-potential enterprises within the healthcare industry, utilizing its extensive resources and expertise to drive growth and innovation.
Over the years, CD Capital has built a diverse portfolio of over 90 companies, showcasing its commitment to fostering innovation in healthcare. The firm has established a structured post-investment support system, which enhances the growth potential of its portfolio companies. CD Capital's notable milestone includes its active participation in the healthcare investment landscape, emphasizing collaboration with entrepreneurs to create a sustainable industrial ecosystem.
CD Capital's strategic focus on the healthcare sector positions it as a key player in the Asian venture capital market. The firm continues to explore opportunities that align with its investment thesis, aiming to contribute to advancements in medical technology and life sciences.
CD Capital primarily invests in the medical technology and life sciences sectors, seeking opportunities driven by technological innovation. The firm operates across various stages of company growth, including seed, Series A, Series B, Series C, and growth equity. This broad investment strategy allows CD Capital to engage with startups at different points in their development, providing tailored support to meet their unique needs.
The firm emphasizes a structured post-investment support system, which is designed to empower entrepreneurs and enhance the growth potential of its portfolio companies. CD Capital looks for high-potential enterprises that can emerge as industry leaders, leveraging its extensive industry resources and research capabilities within the Chinese healthcare sector. This focus on technological innovation and collaboration with entrepreneurs is central to CD Capital's investment strategy.
CD Capital has invested in over 90 companies, showcasing a diverse portfolio within the healthcare sector. Notable portfolio companies include:
This diverse portfolio reflects CD Capital's commitment to investing in innovative solutions that address critical needs in the healthcare sector.
Ching Tan: Founding Partner at CD Capital, Ching has extensive experience in venture capital and a strong background in healthcare investments. He has led numerous successful funding rounds and is known for his strategic insights into the medical technology sector.
Larissa Lin: Partner at CD Capital, Larissa specializes in life sciences investments. She has a proven track record of identifying high-potential startups and providing them with the necessary resources to scale effectively.
Tianji Zhu: Partner at CD Capital, Tianji brings expertise in biotech investments. His background includes significant roles in both venture capital and operational management within the healthcare industry.
To pitch to CD Capital, startups should utilize the contact email bp@cd-pe.com or submit their information through their Crunchbase profile at this link. It is essential to include a detailed pitch deck that outlines the business model, market opportunity, and team qualifications.
Response times may vary, but founders should expect a thorough review process. Warm introductions are preferred, as they can facilitate a more favorable reception of the pitch.
In October 2023, CD Capital successfully hosted its annual meeting and industry forum in Shanghai, focusing on themes of integrity and innovation within the investment landscape. This event highlighted the firm's commitment to fostering collaboration and knowledge sharing among industry stakeholders.
CD Capital continues to maintain an active presence in the healthcare investment space, with a portfolio exceeding 90 investments totaling over $1.4 billion. The firm remains focused on identifying and supporting high-potential enterprises in the medical technology and life sciences sectors.
What are CD Capital's investment criteria?
CD Capital primarily invests in the medical technology and life sciences sectors, focusing on high-potential enterprises driven by technological innovation. The firm seeks opportunities across various stages, including seed, Series A, Series B, Series C, and growth equity.
How can startups apply or pitch to CD Capital?
Startups interested in pitching to CD Capital can reach out via their Crunchbase profile at this link or email them directly at bp@cd-pe.com. It is advisable to include a comprehensive pitch deck that outlines the business model, market opportunity, and team background.
What makes CD Capital different from other venture capital firms?
CD Capital distinguishes itself through its structured post-investment support system, which enhances the growth potential of its portfolio companies. The firm leverages its extensive network and resources within the healthcare industry to drive innovation and collaboration.
What is the geographic scope of CD Capital's investments?
CD Capital primarily focuses on investments within Asia, particularly in the healthcare and biotech sectors. The firm aims to capitalize on the growing demand for healthcare solutions in the region.
What is the typical check size for investments made by CD Capital?
While specific check sizes are not disclosed, CD Capital invests across various stages, indicating a flexible approach to funding that can accommodate different financing needs of startups.
What kind of post-investment involvement can portfolio companies expect?
CD Capital provides structured post-investment support, which includes access to industry resources, mentorship, and strategic guidance to help portfolio companies scale effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.